November 01, 2023 | 11:00 - 2:45 PM
The webinar series is part of a larger effort led by NINDS to develop a Research Roadmap for ME/CFS, which will identify research priorities to move the field toward translational studies and clinical trials. Learn more about the roadmap process on the NANDS Council ME/CFS Research Roadmap Working Group page.
Agenda
Time | Topic | Speakers/Moderators |
11:00 AM ET | Opening Remarks | Vicky Whittemore, PhD NINDS |
11:05 AM ET | Oved Amitay, PhD Solve M.E. |
|
11:08 AM ET | Lived Experience Perspective | Hayla Sluss, PhD University of Massachusetts |
Session 1: Large Data-sets and Genome Wide Association Studies (GWAS) | ||
11:15 AM ET | Genetic Risk Factors of ME/CFS: A Critical Review (GWAS) | Chris Ponting, PhD University of Edinburgh |
11:45 AM ET | Combinatorial Analysis of Genetic Risk Factors for ME/CFS, UK Biobank | Stephen Gardner, PhD PrecisionLife |
12:10 PM ET | Genetic Susceptibility in Long COVID and ME/CFS: Long COVID Host Genetics Initiative (international network) | Hanna Ollila, PhD University of Helsinki Vilma Lammi, PhD University of Helsinki Anniina Maria Tervi, PhD University of Helsinki |
12:35 PM ET | The Use of Large public Biobanks for Genotype/Phenotype Analysis: Industry Perspective | Slavé Petrovski, PhD AstraZeneca |
12:55 PM ET | Q&A Session | |
1:05 PM ET | Break | |
Session 2: Enriched Cohorts and Epigenetics | ||
1:25 PM ET | Characterizing the Genetic Basis of ME/CFS Through Case-Control and Family Studies | Fereshteh Jahaniani, PhD Stanford Varuna Chander, PhD Stanford |
1:50 PM ET | Contribution of Epigenomics to ME/CFS Pathogenesis: Past, Present and Future | Alain Moreau, PhD Université de Montréal |
2:20 PM ET | Closing Remarks | Kristina Allen-Brady, PhD University of Utah |
2:35 PM ET | Adjourn |
Contact
Read Transcript(pdf, 428 KB)